Treatment of oral lichen planus with topical pimecrolimus 1% cream

被引:32
作者
Esquivel-Pedraza, L
Fernández-Cuevas, L
Ortíz-Pedroza, G
Reyes-Gutiérrez, E
Orozco-Topete, R
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Dermatol, Mexico City 14000, DF, Mexico
[2] Univ Intercontinental, Sch Dent, Tlalpan 14420, Mexico
[3] Univ Latinoamer, Mexico City, DF, Mexico
关键词
D O I
10.1111/j.0007-0963.2004.05875.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:771 / 773
页数:3
相关论文
共 7 条
[1]   ORAL LICHEN-PLANUS - A DEMOGRAPHIC-STUDY [J].
AXELL, T ;
RUNDQUIST, L .
COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1987, 15 (01) :52-56
[2]   Macrolactam immunomodulators for topical treatment of inflammatory skin diseases [J].
Bornhövd, E ;
Burgdorf, WHC ;
Wollenberg, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) :736-743
[3]   The clinical manifestations and treatment of oral lichen planus [J].
Eisen, D .
DERMATOLOGIC CLINICS, 2003, 21 (01) :79-+
[4]   Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells [J].
Kalthoff, FS ;
Chung, J ;
Stuetz, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (01) :85-92
[5]   Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis [J].
Nghiem, P ;
Pearson, G ;
Langley, RG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (02) :228-241
[6]  
Schopf Rudolf E, 2002, Curr Opin Investig Drugs, V3, P720
[7]  
Vente C, 1999, BRIT J DERMATOL, V140, P338